- Home
- CELZ vs CDIO Comparison
CELZ vs CDIO Comparison
Compare CELZ & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- CDIO
- Stock Information
- Founded
- CELZ 1998
- CDIO 2017
- Country
- CELZ United States
- CDIO United States
- Employees
- CELZ N/A
- CDIO N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CELZ Health Care
- CDIO Health Care
- Exchange
- CELZ Nasdaq
- CDIO Nasdaq
- Market Cap
- CELZ 7.4M
- CDIO 6.4M
- IPO Year
- CELZ N/A
- CDIO N/A
- Fundamental
- Price
- CELZ $2.71
- CDIO $4.39
- Analyst Decision
- CELZ
- CDIO Buy
- Analyst Count
- CELZ 0
- CDIO 1
- Target Price
- CELZ N/A
- CDIO $60.00
- AVG Volume (30 Days)
- CELZ 228.6K
- CDIO 40.4K
- Earning Date
- CELZ 08-08-2025
- CDIO 08-11-2025
- Dividend Yield
- CELZ N/A
- CDIO N/A
- EPS Growth
- CELZ N/A
- CDIO N/A
- EPS
- CELZ N/A
- CDIO N/A
- Revenue
- CELZ $14,000.00
- CDIO $19,902.00
- Revenue This Year
- CELZ N/A
- CDIO $1,434.82
- Revenue Next Year
- CELZ N/A
- CDIO $4,661.91
- P/E Ratio
- CELZ N/A
- CDIO N/A
- Revenue Growth
- CELZ 55.56
- CDIO N/A
- 52 Week Low
- CELZ $1.69
- CDIO $3.22
- 52 Week High
- CELZ $6.90
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- CELZ 51.69
- CDIO 50.34
- Support Level
- CELZ $2.70
- CDIO $4.11
- Resistance Level
- CELZ $2.85
- CDIO $4.73
- Average True Range (ATR)
- CELZ 0.31
- CDIO 0.33
- MACD
- CELZ -0.03
- CDIO 0.10
- Stochastic Oscillator
- CELZ 18.95
- CDIO 65.03
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.